Clinical Trials
3 trialsNCT03667170 2026-03-25
KN035 for dMMR/MSI-H Advanced Solid Tumors
3D Medicines
Phase 2 Recruiting
NCT05959356 2025-12-17
CEIL
Sun Yat-sen University
Phase 2 Recruiting
NCT06321081 2024-03-20
ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC
Beijing Hospital
Phase 2 Recruiting